Key Updates to Board Meeting Agenda
A Board Meeting is scheduled for Wednesday, August 12, 2026. The agenda, previously communicated, included the consideration and approval of the Unaudited Consolidated & Standalone Financial Results for the quarter ended June 30, 2026 (Q1 FY27).
This filing adds one additional item of business to the agenda:
1. Evaluation of a proposal for raising funds through the issuance of equity shares, convertibles, and/or any other eligible securities on a preferential basis. This proposal is subject to obtaining all necessary regulatory and statutory approvals, including the approval of the company's shareholders.
Regulatory and Compliance Information
The filing also confirms compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's internal codes. The "Trading Window" for dealing in the company's equity shares has been closed for all Designated Persons and their Immediate Relatives since July 01, 2026. The trading window will reopen 48 hours after the declaration of the Financial Results for the quarter ended June 30, 2026.
Financial Impact
Financial impact of the proposed fundraising is not quantified in the disclosure. The specifics of the fundraise, including the amount and instrument details, are pending board evaluation and subsequent approvals.
#Tags: #NaturalCapsules #Fundraising #SEBIDisclosure #RegulatoryCompliance #BoardMeeting